Valuation : Guided Therapeutics Inc

Market Cap 22.4M 19.3M 18.09M 16.52M 31.12M 2.14B 31.22M 215M 83.76M 1.08B 84.09M 82.26M 3.58B P/E 2024
-3x
P/E 2025 -12.7x
Enterprise Value 25.27M 21.78M 20.42M 18.64M 35.11M 2.42B 35.23M 242M 94.52M 1.22B 94.89M 92.82M 4.04B EV / Sales 2024
1,649x
EV / Sales 2025 64.4x
Free-Float
63.48%
Yield 2024 *
-
Yield 2025 -
Manager TitleAgeSince
Chief Executive Officer 70 06/03/2023
Chief Tech/Sci/R&D Officer 70 02/12/2010
Director TitleAgeSince
Director/Board Member 70 01/12/2016
Director/Board Member 76 10/04/2006
Chairman 67 01/10/2013
Change 5-day change 1-year change 3-year change Capi.($)
+13.33%-.--% - - 22.69M
-1.35%-1.13%+27.04%+14.12% 233B
+0.18%-1.27%+5.25%-17.37% 152B
+1.51%-1.64%-21.37%+23.59% 130B
+0.36%-7.01%-55.71%-12.92% 67.64B
+0.29%+0.47%+11.06%+18.65% 51.85B
+0.66%-1.69%-16.57%-13.62% 50.91B
-2.44%-3.25%+23.11%+28.29% 44.46B
-1.56%+0.97%+39.32%+47.34% 41.39B
-5.31%-1.74%+117.39%+36.28% 34.38B
Average +0.54%-1.39%+14.39%+13.82% 89.46B
Weighted average by Cap. -0.48%-1.49%+8.68%+9.42%

Financials

2024 2025
Net sales 7K 6.03K 5.66K 5.16K 9.73K 669K 9.76K 67.1K 26.18K 338K 26.28K 25.71K 1.12M 767K 661K 620K 566K 1.07M 73.31M 1.07M 7.35M 2.87M 37M 2.88M 2.82M 123M
Net income -2.42M -2.08M -1.95M -1.78M -3.36M -231M -3.37M -23.17M -9.04M -117M -9.07M -8.88M -387M -3.2M -2.75M -2.58M -2.36M -4.44M -305M -4.45M -30.64M -11.95M -154M -12M -11.74M -511M
Net Debt 1.77M 1.53M 1.43M 1.31M 2.46M 169M 2.47M 16.98M 6.62M 85.44M 6.65M 6.5M 283M 2.88M 2.48M 2.32M 2.12M 4M 275M 4.01M 27.57M 10.76M 139M 10.8M 10.56M 460M
Logo Guided Therapeutics Inc
Guided Therapeutics, Inc. is a medical technology company. The Company is focused on developing medical devices that have the potential to improve healthcare. The Company’s primary focus is the sales and marketing of its LuViva Advanced Cervical Scan non-invasive cervical cancer detection device. The underlying technology of LuViva primarily relates to the use of biophotonics for the non-invasive detection of cancers. LuViva is designed to identify cervical cancers and precancers painlessly, non-invasively and at the point of care by scanning the cervix with light, then analyzing the reflected and fluorescent light. LuViva is designed to provide a less invasive and painless alternative to conventional tests for cervical cancer screening and detection. Additionally, LuViva is designed to improve patient well-being not only because it eliminates pain, but also because it is convenient to use and provides rapid results at the point of care.
Employees
-